Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05776082Recruiting
Study how healthy pregnancy heart risk affects outcomes
This study looks at how cardiovascular (heart and blood vessel) health during pregnancy is linked to pregnancy outcomes. It may help doctors better predict and improve outcomes by using information from routine prenatal care.
Hangzhou, ZhejiangAges 20–49 - NCT06532916Recruiting
Comparing two tooth-colored filling materials for small cavities and wear
This study tests two types of tooth-colored filling materials (a flowable one and a preheated one) to see which keeps its color and resists wear better. It may be a good option if you have a small cavity, chip, or natural wear on a front tooth or the side/back of a tooth.
IrbidAges 18 years+ - NCT07211282Recruiting
Activity tracking for late-stage cardiac rehab
This trial uses a smartphone app to monitor and guide your physical activity during the final phase of cardiac rehab. It aims to help you safely stay active and improve your recovery.
Edegem, AntwerpAges 18 years+ - NCT07003087Enrolling by invitation
AI gait analysis for shoe sole adjustments
This study uses a 2D video and AI to analyze how you walk. The goal is to adjust your shoe soles to help with discomfort in your legs or feet.
TaichungAges 20–70 - NCT07211347RecruitingPhase 4
Nerve block for electrical storm
This trial tests whether injecting numbing medicine around neck nerves (stellate ganglion block) can calm dangerous heart rhythms called electrical storm. It's for people with heart disease whose abnormal rhythms keep happening despite usual medications.
São Paulo, São PauloAges 18 years+ - NCT07706244Recruiting
Does reducing pre-surgery anxiety help orthopedic patients recover better?
This study tests if a program to reduce anxiety before surgery (Enhanced Recovery After Surgery) improves how patients feel one year after major orthopedic surgery like knee, hip, or spine procedures, compared to standard care.
Hualien City, Hualien CountyAges 20–100 - NCT07209501Enrolling by invitation
Aromatherapy for stem cell transplant patients
This trial tests if inhaling essential oils can help patients who are having a stem cell transplant after high-dose chemotherapy. It aims to see if this is a feasible and acceptable way to feel better during treatment.
SingaporeAges 21–99 - NCT07096219Enrolling by invitation
Catheter Ablation for Leaky Mitral Valve in Persistent Atrial Fibrillation
This trial tests if catheter ablation—a procedure to fix heart rhythm—can help people with a leaky mitral valve that is caused by atrial fibrillation (functional mitral regurgitation). If you have persistent atrial fibrillation and moderate leaky valve, you may benefit from this treatment.
Guangzhou, GuangdongAges 18–75 - NCT06102824RecruitingPhase 2
Organoid-guided treatment for advanced breast cancer
This trial tests whether using a miniature version of your tumor grown in a lab can help choose the best treatment for advanced breast cancer. It compares this personalized approach to standard care.
Guangzhou, GuangdongAges 18–80 - NCT07208734Enrolling by invitation
Personalized brain stimulation for memory loss in older adults
This trial tests a personalized brain stimulation treatment for older adults with mild memory or thinking problems caused by Alzheimer's disease. It aims to see if tailored stimulation can improve cognitive function.
Beijing, Beijing MunicipalityAges 50–90 - NCT07468006Recruiting
Comparing carbon dioxide measurements in critically ill children
This trial tests if a sticker on the skin can accurately measure carbon dioxide levels in the blood, reducing the need for needle sticks in children in the intensive care unit.
BrnoAges 1–18 - NCT06102889Enrolling by invitation
Using liquid biopsies to guide treatment for pancreatic cancer
This study is testing a way to use blood samples, called liquid biopsies, to find tiny bits of cancer left after surgery and choose the best follow-up treatments for pancreatic cancer. It might help doctors personalize care for each patient.
StockholmAges 18 years+ - NCT06994871Enrolling by invitation
Exercise and liver fat in fatty liver disease
This study tests if different types of exercise can reduce fat in the liver for people with metabolic fatty liver disease. It might help if you are looking for a non-drug way to improve your liver health.
Nanjing, JiangsuAges 18–45 - NCT05742425RecruitingPhase 2
Immunotherapy with chemo and targeted drug for colon cancer in the belly
This Phase 2 trial tests serplulimab (immunotherapy) combined with FOLFIRI chemo plus bevacizumab for colon cancer that has spread to the lining of the abdomen (peritoneal metastases). It aims to shrink these tumors and improve outcomes when surgery can’t fully remove them.
Huzhou, ZhejiangAges 18–75 - NCT07207278Recruiting
Genetics and immune study of lung signet ring cell cancer
This research study is looking at the unique genetic makeup and immune features of a rare type of lung cancer called signet ring cell carcinoma. By studying tumor samples and medical data, researchers hope to find better ways to understand and eventually treat this cancer.
Hangzhou, ZhejiangAges 18–85 - NCT07206823Recruiting
Romiplostim N01 plus rituximab for ITP that didn't respond to oral TPO-RA
This trial tests a new combination of two medicines—romiplostim N01 (a shot to raise platelets) and rituximab (an infusion that calms the immune system)—for people with primary immune thrombocytopenia (ITP) who have not had enough improvement from oral TPO-RA pills like hetrombopag or eltrombopag. It aims to see if this combination works better and is safe.
Suzhou, JiangsuAges 14 years+ - NCT07206836Recruiting
Enhanced recovery after colostomy reversal in children
This trial compares two ways to care for children after colostomy reversal surgery: standard care or an enhanced recovery program designed to speed up healing.
Faisalābad, Punjab ProvinceAges 2–13 - NCT06689917Recruiting
JY231 injection for relapsed B-cell lymphoma or leukemia
This trial tests a new cell therapy called JY231 for people whose B-cell lymphoma or leukemia has come back or not responded to standard treatments. The therapy targets a protein on cancer cells called CD19 and may help your immune system fight the cancer.
Wuhan, HubeiAges 18–75 - NCT05576389RecruitingPhase 2
Fluzoparib plus camrelizumab before surgery for BRCA-related HER2-negative breast cancer
This study tests a combination of two drugs – fluzoparib (a PARP inhibitor) and camrelizumab (an immunotherapy) – given before surgery for early-stage or locally advanced HER2-negative breast cancer in people with an inherited BRCA mutation. The goal is to see if this treatment can shrink the tumor and improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07205471Recruiting
Partial spleen removal via laparoscopy for cirrhosis-related hypersplenism
This study is testing a keyhole surgery to remove part of an enlarged spleen in people with cirrhosis. It aims to improve low blood counts and reduce the risk of further bleeding from stomach or esophagus veins.
Yangzhou, JiangsuAges 18 years+ - NCT06859944Recruiting
Comparing two types of frozen embryo transfer preparation
This trial compares two ways to prepare the uterus for a frozen embryo transfer: a natural cycle or a new method using hormonal stimulation during the early part of the cycle. It may help improve success rates for people using their own eggs and sperm.
BrusselsAges 18–45 - NCT07556653RecruitingEarly Phase 1
New cell therapy for advanced solid tumors
This early-stage trial tests a new allogeneic cell therapy (WTX-212C) designed to fight advanced solid cancers. Researchers want to see if this treatment is safe and how well it works in patients whose cancer has spread.
Hangzhou, ZhejiangAges 18–75 - NCT06682156Recruiting
Switching to carfilzomib for multiple myeloma patients who can't tolerate bortezomib
This trial is for people newly diagnosed with multiple myeloma who are having side effects from their first treatment with bortezomib. It tests switching to a different drug called carfilzomib to see if it works well with fewer side effects.
Suzhou, JiangsuAges 18 years+ - NCT07652138RecruitingPhase 1
RN1201 injection for newly diagnosed multiple myeloma
This trial tests a new drug called RN1201 as a first-line treatment for multiple myeloma, a blood cancer. The study aims to see if it is safe and effective for patients who have never been treated for this condition before.
Suzhou, JiangsuAges 18–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.